ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2185

TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, a Feasibility Study

Megan Clarke1, Julie Herrington2, Tania Cellucci3, Liane Heale4, Mark Matsos5, KAREN BEATTIE2, Roberta A Berard6 and Michelle Batthish3, 1McMaster Universitys, Hamilton, Canada, 2McMaster University, Hamilton, ON, Canada, 3McMaster Children's Hospital, Hamilton, ON, Canada, 4McMaster University, Oakville, ON, Canada, 5McMaster Lupus Clinic, Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, ON, Canada, 6London Health Sciences Centre, London, ON, Canada

Meeting: ACR Convergence 2024

Keywords: Randomized Trial

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The transition from pediatric to adult healthcare is a vulnerable time for youth with chronic disease, with risks of disengagement from care and subsequent complications of poorly managed disease. Health coaching helps patients gain the knowledge, skills, tools and confidence to become active participants in their care. For youth with a rheumatic disease approaching transfer to adult care, transition coaching may be effective in supporting them psychologically and socially as they gain the skills and tools necessary to independently manage their health. To address this, we designed the TRACER (Transition to Adulthood through Coaching and Empowerment in Rheumatology) study to assess the feasibility of conducting a multi-centred RCT of a Transition Coach Intervention (TCI) in youth transferring from pediatric to adult rheumatology care.

Methods: Youth 17-18-years-old with any rheumatic disease were recruited at their last pediatric rheumatology appointment at McMaster Children’s Hospital or Children’s Hospital at London Health Sciences Centre in Ontario, Canada. Participants were randomized to the TCI or control group. Participants received the Youth Transition Roadmap which reviews five domains of healthcare transition: Self-Advocacy, Medication Management, General Health, Lifestyle Issues and Future Planning related to education and vocation. TCI participants also received virtual one-on-one monthly sessions for 8-months at a time convenient to the participant. Primary feasibility outcomes were consent rate (≥85%), enrollment from London ( >30%), TCI completion rate (≥90%), and completion of data collection (≥90%). Secondary clinical outcomes collected at baseline, 8- and 11-months included the Transition-Q (transition readiness questionnaire; 1-100), and PROMIS® self-efficacy measures.

Results: Of 66 patients approached, 30 (46%) consented, 16 (53%) of whom were enrolled from London. Of those consented, 2 withdrew after consenting but prior to collecting baseline data and starting the intervention. Participant characteristics are shown in Table 1. To date, 15 (50%) have reached the 8-month follow-up period. TCI attendance rate was 95.8%. For those who have received 8-month follow-up questionnaires, 90.7% of assessments were completed. At baseline mean (SD) Transition-Q scores for the TCI group were 72.3 (18.1) and 65.4 (15.3) in the control group. PROMIS responses in the TCI group appear to show an increase in self-efficacy after the TCI intervention (Figure 1). PROMIS responses at 8-months in both groups are shown in Figure 2, which suggests a trend in improvement in all domains.

Conclusion: Our study met all feasibility outcomes except consent rate, suggesting that we will need to approach a large number of patients in order to meet our sample size target in a large multi-centre RCT. PROMIS self-efficacy measures appear to improve after the TCI; however, sample size is limited, and data collection is ongoing. These findings will serve as a foundation for a robust, multi-centred RCT of a transition coaching intervention with the goal of enhancing the physical, mental, and social well-being of youth with rheumatic disease transitioning into adult care.

Supporting image 1

Demographic Characteristics of TRACER Participants

Supporting image 2

PROMIS responses in the TCI group at baseline (n=13) and 8-months (n=7). Physical health responses include if the participant was confident in: A) remembering to take medications as prescribed; B) listing medications including the doses and schedules; C) managing symptoms when at home. Mental health responses include if the participant was confident in: D) finding ways to manage stress; E) can handle upsetting situations; F) can handle the stress of going for treatment of their medical condition. Social health responses include if the participant was confident in: G) talking about their health problems with someone; H) communicating well with doctors and nurses; I) having people who they can turn to for help with problems.

Supporting image 3

PROMIS responses from control (n=8) and TCI (n=7) groups at 8-months. Physical health responses include if the participant was confident in: A) remembering to take medications as prescribed; B) listing medications including the doses and schedules; C) managing symptoms when at home. Mental health responses include if the participant was confident in: D) finding ways to manage stress; E) can handle upsetting situations; F) can handle stress associated with treatment of their medical condition. Social health responses include if the participant was confident in: G) talking about their health problems with someone; H) communicating well with doctors and nurses; I) having people who they can turn to for help with problems. TCI = transition coach intervention.


Disclosures: M. Clarke: None; J. Herrington: None; T. Cellucci: None; L. Heale: Novartis, 5; M. Matsos: AbbVie/Abbott, 6, AstraZeneca, 6, GlaxoSmithKlein(GSK), 6; K. BEATTIE: None; R. Berard: AbbVie/Abbott, 1, Sandoz, 1; M. Batthish: Abbvie, 6, Novartis, 2, Viatris, 12, Unrestricted Educational Grant.

To cite this abstract in AMA style:

Clarke M, Herrington J, Cellucci T, Heale L, Matsos M, BEATTIE K, Berard R, Batthish M. TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, a Feasibility Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/tracer-transition-to-adulthood-through-coaching-and-empowerment-in-rheumatology-a-feasibility-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tracer-transition-to-adulthood-through-coaching-and-empowerment-in-rheumatology-a-feasibility-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology